carfilzomib
Carfilzomib is derived from epoxomicin, a natural product that was shown by the laboratory of Craig Crews at Yale University to inhibit the proteasome. It is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.. Reference standards of Carfilzomib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => (S)-4-Oxo-homophenylalanine Hydrochloride
[catalogue_number] => PA 30 63510
[category_ids] => ,97,80,78,70,82,
[chemical_name] =>
[weight] => 229.66
[form] => C10H12ClNO3
[cas] => 168154-76-5
[pslug] => 168154-76-5-s-4-oxo-homophenylalanine-hydrochloride-pa3063510
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(S)-4-Oxo-homophenylalanine Hydrochloride
Catalogue No.:PA 30 63510
Molecular Formula : C10H12ClNO3
Molecular Weight : 229.66
stdClass Object
(
[pname] => (4S)-4-Amino-2,6-dimethyl-1-hepten-3-one 2,2,2-Trifluoroacetate
[catalogue_number] => PA 30 63740
[category_ids] => ,79,97,69,78,70,82,
[chemical_name] =>
[weight] => 269.26
[form] => C11H18F3NO3
[cas] => 1619233-32-7
[pslug] => 1619233-32-7-4s-4-amino-2-6-dimethyl-1-hepten-3-one-2-2-2-trifluoroacetate-pa3063740
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(4S)-4-Amino-2,6-dimethyl-1-hepten-3-one 2,2,2-Trifluoroacetate
Catalogue No.:PA 30 63740
Molecular Formula : C11H18F3NO3
Molecular Weight : 269.26